Societe Generale Effekten (S28922) Cotización

Don't know about that. This guy is an International schiester. Visit that link and see all the different countries he operates in.



https://investorshub.advfn.com/uimage/uploads/2024/11/24/wnlumScreenshot_2024-11-24_11.59.20_AM.png
https://investorshub.advfn.com/

Bigbang, I have noticed, over the last years, no matter what answer any long term shareholder provides, you are never satisfied . So I am just going to ignore your question.

Euro, this one is a hold for dear life.

Still 4.2 million class b shares yet to convert, maybe that explains part of the discrepancy?

Yes, all the new programs are so exciting Someone is upset here boohoo. Is someone having a bad weekend? Its called panic and shorts are unable to deal with new reality.
Will bring this back up in Spring when it is clear that the MAA is going nowhere.
So you are disregarding the fact

Yup, i'm reading "Crossfire" now. Marrs said we live in a banana republic.

I hope this thing will start to move soon

XRP🌉🌉⛓️

Nuro.ai - See supervised nuro.ai Prius around ofter in the MV area. Apparently, they are now pilot testing the real deal on MV roads. This was from last week in an area of MV I am not familiar with. No windows, no dirver, just sensors.

https://www.youtube.com/watch?v=JK7G-7Arf4M&t=

Navy, it’s been a while. We are GOLDEN indeed. I dare anyone who dispute Bessent’s positive views on the GSEs.

Hi Jake,

Are you suggesting a cash holding level of 55.3%? If so how have you calculated that?

I do understand the forward returns based on the figures.

Thanks

Will

What sux is these players that buy 10's of millions of shares in the trips will flip out simultaneously. Screwing the Etrader Swing rookies.Thats why the OTC sux. Until the greedy pigs relax, the otc will remain in the sorry state that its in.

The odd thing is that there were several failures in this space of drugs that clearly have good antiviral activity. The analyst just didn’t push back. I’m fact zelicapavir itself failed in the standard risk RSVP study. The most notable failure was Lumicitabine which JNJ picked up from Alios which ha

Rep Jim Hill 2018 networth 7 mil, 2022 17 mil.....

Some good discussion on the Rett trial design and lack of statistical significance for a treatment that likely really does "work". As such, I "upvote" good arguments on both sides. Now, from both the company's and investor's perspective the key is: MAA filing for Alzheimer's in Q4 2024. Delivery

Rep Gottheimer 2018 networth 9 mil, 2022 32 mil.....

I'm holding all my shares. TXTM to the moon baby!

Ted Cruz, 2018 networth 3.5 mil, 2022 6.7 mil.....

Cry even harder than that! I know you can do it! Let the LIBERAL TEARS flow bwahahahahahahahahah!!!!

HILARIOUS seeing all the PISSED-OFF socialists MELTING DOWN in the light of REALITY as their WORST NIGHTMARE is set to begin on January 20th 😃

Keep the CRYING

OK Senator Markwayne Mullin’s Net Worth QUADRUPLED Between 2018-2022 From $12m -> $63m

https://x.com/WallStreetApes/status/1860709449431724308

Are you seriously suggesting an IND between those two (assumed) approved therapies would not be accepted, and that they’d worry about that, if, for instance, Merck and NWBO have already worked months designing the trials. Seriously? You couldn’t say that with a straight face.

(Wheth

I dont want an update. I want contracts to be signed and pr’s issued. And buildings built. Petroleum flowing. And additives mixed…..

😰📖😓

https://www.youtube.com/watch?v=kVcpc0iL2aQ

No one is talking about releasing shares, and the company hasn’t done that other than to pay salaries for many years. Thankfully we became profitable enough to even stop that. I was referring to past decisions made years ago to reinforce how loan adverse our CEO is.